Intended for healthcare professionals

Letters Anticholinergic drugs and risk of dementia

Relative risk of developing dementia after being prescribed anticholinergic drugs

BMJ 2018; 363 doi: https://doi.org/10.1136/bmj.k5201 (Published 07 December 2018) Cite this as: BMJ 2018;363:k5201
  1. Roger A Fisken, retired consultant physician
  1. Berkshire
  1. daardon{at}yahoo.com

Richardson and colleagues’ study on anticholinergic drugs and risk of dementia is admirable and very thoroughly carried out.1 The authors do not, however, make a clear statement of what most readers would like to know—namely, the …

View Full Text

Log in

Log in through your institution

Subscribe

* For online subscription